COPD: The 3rd leading cause of death in the United States.
Examine strategies for the recognition & assessment of early symptoms, criteria for diagnosis, & the implementation of a comprehensive patient-centered approach for disease management.
Covering the nationally vetted safe opioid prescribing standards using the FDA blueprint,
this activity includes information on immediate & long acting opioid use, equal analgesic dose changes, drug families & new drug formulations.
